文献速递心外重症与机械循环支持

心力衰竭、左心室辅助装置及心脏移植患者的肠道菌群、内毒素血症、炎症与氧化应激

Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant.
PubMed 文献 · J Heart Lung Transplant · 2020-02-13

该研究纳入452例患者,分析644份血液样本和304份粪便样本,比较不同NYHA分级心衰、左心室辅助装置(LVAD)及心脏移植(HT)患者的肠道菌群与循环标志物。结果显示,随着心衰分级恶化,肠道微生物α多样性逐步降低,LVAD和HT患者同样降低;NYHA IV级患者炎症和氧化应激高于其他组;脂多糖在NYHA IV级、LVAD和HT患者中升高;sCD14在NYHA IV级和LVAD患者中升高,但HT患者未升高。结论认为NYHA IV级心衰患者存在肠道菌群多样性降低及内毒素血症、炎症和氧化应激增加,LVAD和HT后炎症与氧化应激低于NYHA IV级,但肠道多样性降低和内毒素血症持续存在。

要点

  • 心衰分级越差,肠道微生物α多样性越低,LVAD和HT患者同样降低。
  • NYHA IV级患者炎症和氧化应激高于其他组,脂多糖和sCD14升高。
  • LVAD和HT后炎症与氧化应激低于NYHA IV级,但内毒素血症持续。

核心结论

  • NYHA IV级心衰患者存在肠道微生物多样性降低、内毒素血症、炎症和氧化应激增加。
  • LVAD和HT患者炎症与氧化应激低于NYHA IV级,但肠道多样性降低和内毒素血症持续存在。

研究设计与样本

  • 研究纳入452例患者,包括NYHA I-IV级心衰、LVAD和HT患者。
  • 测量644份血液样本中的内毒素血症、炎症和氧化应激标志物。
  • 采用16S rRNA测序分析304份粪便样本的肠道菌群。

主要发现

  • 肠道微生物α多样性随NYHA分级恶化逐步降低,LVAD和HT患者同样降低(p < 0.05)。
  • NYHA IV级患者炎症和氧化应激高于所有其他组(所有p < 0.05)。
  • 脂多糖在NYHA IV级(vs NYHA I-III级)、LVAD和HT患者中升高(p < 0.05)。
  • sCD14在NYHA IV级和LVAD患者中升高(vs NYHA I-III级,p < 0.05),但HT患者未升高。

临床怎么用

  • 对NYHA IV级心衰患者应关注肠道菌群失调及内毒素血症相关炎症和氧化应激。
  • LVAD和HT患者即使炎症和氧化应激改善,仍需关注持续的肠道多样性降低和内毒素血症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gut microbial imbalance may contribute to endotoxemia, inflammation, and oxidative stress in heart failure (HF). Changes occurring in the intestinal microbiota and inflammatory/oxidative milieu during HF progression and following left ventricular assist device (LVAD) or heart transplantation (HT) are unknown. We aimed to investigate variation in gut microbiota and circulating biomarkers of endotoxemia, inflammation, and oxidative stress in patients with HF (New York Heart Association, Class I-IV), LVAD, and HT. METHODS: We enrolled 452 patients. Biomarkers of endotoxemia (lipopolysaccharide and soluble [sCD14]), inflammation (C-reactive protein, interleukin-6, tumor necrosis factor-α, and endothelin-1 adiponectin), and oxidative stress (isoprostane) were measured in 644 blood samples. A total of 304 stool samples were analyzed using 16S rRNA sequencing. RESULTS: Gut microbial community measures of alpha diversity were progressively lower across worsening HF class and were similarly reduced in patients with LVAD and HT (p < 0.05). Inflammation and oxidative stress were elevated in patients with Class IV HF vs all other groups (all p < 0.05). Lipopolysaccharide was elevated in patients with Class IV HF (vs Class I-III) as well as in patients with LVAD and HT (p < 0.05). sCD14 was elevated in patients with Class IV HF and LVAD (vs Class I-III, p < 0.05) but not in patients with HT. CONCLUSIONS: Reduced gut microbial diversity and increased endotoxemia, inflammation, and oxidative stress are present in patients with Class IV HF. Inflammation and oxidative stress are lower among patients with LVAD and HT relative to patients with Class IV HF, whereas reduced gut diversity and endotoxemia persist in LVAD and HT.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Yuzefpolskaya M, Bohn B, Nasiri M, et al. Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant. J Heart Lung Transplant. 2020. PMID: 32139154. doi:10.1016/j.healun.2020.02.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。